Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$140.80 USD
+3.76 (2.74%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $140.63 -0.17 (-0.12%) 7:04 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Brokerage Reports
Ascendis Pharma A/S [ASND/]
Reports for Purchase
Showing records 141 - 160 ( 303 total )
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Q2: SKYTROFA Approved; Aiming for US Launch Plus Multiple Catalysts in Q4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
PaTHway Target Enrollment Achieved, Topline Data Now in Q1:22
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Lonapeg (TC-hGH)/GHD PDUFA Extended to Sept. 25, 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Biotechnology - The Wedbush Monthly Check-Up: June 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Q1 Financials; Next, TC-hGH/pediatric GHD June 25, 2021 PDUFA; Top Pick
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
58-Week OLE TC-PTH/HP Ph 2 Data Shows Durable Treatment Benefit
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Key Takeaways from Virtual NDR on April 14, 2021; Top Pick
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
BEST IDEAS LIST -Adding WEN & Removing JACK
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Ascendis Pharma A/S
Industry: Medical - Biomedical and Genetics
Impressive TC-PTH/HP Phase 2 6-Mo OLE Data at ENDO 2021
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L